Roswell Biotechnologies Secures $32 Million Series A Financing Round

Harnessing the Power of Molecular Electronics to Revolutionize DNA Sequencing SAN DIEGO, Jan. 3, 2019 -- (Healthcare Sales & Marketing Network) -- Roswell Biotechnologies, Inc., the pioneer in the development of a molecular electronics platform for DNA... Diagnostics, Venture Capital Roswell Biotechnologies
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news